With 1.2 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.13 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $167.49 whereas the lowest price it dropped to was $162.05. The 52-week range on THC shows that it touched its highest point at $171.20 and its lowest point at $52.08 during that stretch. It currently has a 1-year price target of $187.83. Beta for the stock currently stands at 2.12.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of THC was up-trending over the past week, with a rise of 2.53%, but this was up by 9.16% over a month. Three-month performance surged to 14.70% while six-month performance rose 34.50%. The stock gained 203.84% in the past year, while it has gained 120.82% so far this year. A look at the trailing 12-month EPS for THC yields 31.26 with Next year EPS estimates of 11.59. For the next quarter, that number is 2.92. This implies an EPS growth rate of 59.67% for this year and 4.00% for next year. EPS is expected to grow by 22.95% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 40.40%.
Float and Shares Shorts:
At present, 99.95 million THC shares are outstanding with a float of 92.73 million shares on hand for trading. On 2024-10-15, short shares totaled 2.4 million, which was 252.99999999999997 higher than short shares on 1726185600. In addition to Dr. Saumya Sutaria M.D. as the firm’s Chairman & CEO, Ms. Paola M. Arbour serves as its Executive VP & Chief Information Officer.
Institutional Ownership:
Through their ownership of 0.99219 of THC’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-09-30, THC reported revenue of $5122000000.0 and operating income of $707000000.0. The EBITDA in the recently reported quarter was $1013000000.0 and diluted EPS was $4.89.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for THC since 10 analysts follow the stock currently. There are 9 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 1 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
Analysts have provided yearly estimates in a range of $11.26205 being high and $10.93916 being low. For THC, this leads to a yearly average estimate of $11.14464. Based on analyst estimates, the high estimate for the next quarter is $0 and the low estimate is $0. The average estimate for the next quarter is thus $0.
